Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers

There is an unmet need for an intravenous (i.v.) neuraminidase inhibitor, particularly for patients with severe influenza who cannot take oral medication. Two phase I pharmacokinetic and safety studies of i.v. oseltamivir were carried out in healthy volunteers. The first was an open-label, randomize...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brennan, Barbara J., Davies, Brian, Cirrincione-Dall, Georgina, Morcos, Peter N., Beryozkina, Anna, Chappey, Colombe, Aceves Baldó, Pau, Lennon-Chrimes, Sian, Rayner, Craig R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421873/
https://ncbi.nlm.nih.gov/pubmed/22733065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00200-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados